CSL LTD (CMXHF:OTCMKTS)
$121.1 -4.93 (-3.9118%)
Analysed CSL LTD (CMXHF:OTCMKTS) News Sources
Why Is CSL (ASX:CSL) Launching Its New Flu Vaccine First In The UK?
23-09-2026
yahoo.com
Former Gilead CIO and CSL Chief Digital & Information Officer Mark Hill Joins Sware Board of Directors
29-09-2026
yahoo.com
CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign
29-09-2026
yahoo.com
CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
04-10-2026
yahoo.com
CSL to pay up to $1.6 bln to develop rare disease drug; shares rise
05-10-2026
yahoo.com
CSL (ASX:CSL) Could Be 15% Undervalued After Its $355 Million Alentis Deal
06-10-2026
yahoo.com
Haemonetics stock surges 17% on CSL Plasma supply deal update
08-10-2026
yahoo.com
Haemonetics shares jump as CSL sets 2027 rollout of plasma devices
08-10-2026
proactiveinvestors.com
CSL Reports Positive Top-Line Phase 3b Results Supporting Planned Expanded Pediatric Filing for ANDEMBRY® (garadacimab-gxii) in Children with Hereditary Angioedema (HAE)
27-07-2026
yahoo.com
HRMY vs. CSLLY: Which Stock Is the Better Value Option?
06-10-2026
yahoo.com
What is the current price of CSL LTD (CMXHF:OTCMKTS)?
The current price of CSL LTD (CMXHF:OTCMKTS) is $121.1.
CSL LTD (CMXHF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CSL LTD (CMXHF:OTCMKTS) since the previous trading day is $-4.93.
CSL LTD (CMXHF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CSL LTD (CMXHF:OTCMKTS) since the previous trading day is -3.9118%.
What is the most recent average sentiment score for CSL LTD (CMXHF:OTCMKTS)?
The most recent average sentiment score for CSL LTD (CMXHF:OTCMKTS) is 73 out of 100.
What is the most recent average sentiment for CSL LTD (CMXHF:OTCMKTS)?
The most recent sentiment for CSL LTD (CMXHF:OTCMKTS) is .
SEC-8K** Filing Available For CSL LTD (CMXHF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.